The DOI matches its Crossref record; 16 of the 18 references it cites were found in a registry or an index.
A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology
Open accessPublished version of a preprint
Abstract
The ongoing pandemic spread of a new human coronavirus, SARS-CoV-2, which is associated with severe pneumonia/disease (COVID-19), has resulted in the generation of tens of thousands of virus genome sequences. The rate of genome generation is unprecedented, yet there is currently no coherent nor accepted scheme for naming the expanding phylogenetic diversity of SARS-CoV-2. Here, we present a rational and dynamic virus nomenclature that uses a phylogenetic framework to identify those lineages that contribute most to active spread. Our system is made tractable by constraining the number and depth of hierarchical lineage labels and by flagging and delabelling virus lineages that become unobserved and hence are probably inactive. By focusing on active virus lineages and those spreading to new locations, this nomenclature will assist in tracking and understanding the patterns and determinants of the global spread of SARS-CoV-2.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The B.1.617 lineage, which is divided into three sublineages according to the PANGO classification 12 , derives from the B.1 lineage (D614G).”
From Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization (2021) · cites this paper as [12]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A novel coronavirus from patients with pneumonia in China, 2019
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244
MAFFT: a novel method for rapid multiple sequence alignment based on fast Fourier transform
Katoh, K. (2002) · Nucleic Acids Research · doi:10.1093/nar/gkf436 · Cited by 17,027
IQ-TREE 2: New Models and Efficient Methods for Phylogenetic Inference in the Genomic Era
Minh, B. Q., Schmidt, H. A., Chernomor, O., Schrempf, D., Woodhams, M. D., von Haeseler, A., & Lanfear, R. (2020) · Molecular Biology and Evolution · doi:10.1093/molbev/msaa015 · Cited by 16,873
Lu, R., Zhao, X., Li, J., Niu, P., Yang, B., Wu, H., Wang, W., Song, H., Huang, B., Zhu, N., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30251-8 · Cited by 11,907
Self-citationA new coronavirus associated with human respiratory disease in China
Wu, F., Zhao, S., Yu, B., Chen, Y.-M., Wang, W., Song, Z.-G., Hu, Y., Tao, Z.-W., Tian, J.-H., Pei, Y.-Y., et al. (2020) · Nature · doi:10.1038/s41586-020-2008-3 · Cited by 11,688
Self-citationUltrafast Approximation for Phylogenetic Bootstrap
Minh, B. Q., Nguyen, M. A. T., & von Haeseler, A. (2013) · Molecular Biology and Evolution · doi:10.1093/molbev/mst024 · Cited by 4,844
GISAID: Global initiative on sharing all influenza data – from vision to reality
Shu, Y., & McCauley, J. (2017) · Eurosurveillance · doi:10.2807/1560-7917.es.2017.22.13.30494 · Cited by 3,039
Yang, Z. (1994) · Journal of Molecular Evolution · doi:10.1007/bf00160154 · Cited by 2,960
(1986) · Cited by 2,570
Smith, D. B., Bukh, J., KUIKEN, C. L., Muerhoff, A. S., Rice, C. M., Stapleton, J. T., & Peter Simmonds, K. (2013) · Hepatology · doi:10.1002/hep.26744 · Cited by 1,352
Cited by
Sorted by citations
Items 301–400 of 1,013
Mutational spectrum of SARS-CoV-2 during the global pandemic
Yi, K., Kim, S. Y., Bleazard, T., Kim, T., Youk, J., & Ju, Y. S. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00658-z · Cited by 70
One Year of SARS-CoV-2: Genomic Characterization of COVID-19 Outbreak in Qatar
Benslimane, F. M., Al-Khatib, H. A., Al-Jamal, O., Albatesh, D., Boughattas, S., Ahmed, A. A., Bensaad, M., Younuskunju, S., Mohamoud, Y. A., Badr, M. A., et al. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.768883 · Cited by 66
Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responsesPreprint
Dejnirattisai, W., Huo, J., Zhou, D., Zahradník, J., Supasa, P., Liu, C., Duyvesteyn, H. M. E., Ginn, H. M., Mentzer, A. J., Tuekprakhon, A., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.12.03.471045 · Cited by 69
Genomic Evidence of In-Flight Transmission of SARS-CoV-2 Despite Predeparture Testing
Swadi, T., Geoghegan, J. L., Devine, T., McElnay, C., Sherwood, J., Shoemack, P., Ren, X., Storey, M., Jefferies, S., Smit, E., et al. (2021) · Emerging infectious diseases · doi:10.3201/eid2703.204714 · Cited by 67
Self-citationMakarenkov, V., Mazoure, B., Rabusseau, G., & Legendre, P. (2021) · BMC Ecology and Evolution · doi:10.1186/s12862-020-01732-2 · Cited by 67
Vega‐Magaña, N., Sánchez-Sánchez, R., Hernández‐Bello, J., Venancio-Landeros, A. A., Rodríguez, M. P., Vega-Zepeda, R. A., Galindo-Ornelas, B., Díaz-Sánchez, M., García‐Chagollán, M., Ojeda, G. M., et al. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.672562 · Cited by 67
Lane, C. R., Sherry, N. L., Porter, A. F., Duchêne, S., Horan, K., Andersson, P., Wilmot, M., Turner, A., Dougall, S., Johnson, S. A. S., et al. (2021) · The Lancet Public Health · doi:10.1016/s2468-2667(21)00133-x · Cited by 68
Mutations that adapt SARS-CoV-2 to mink or ferret do not increase fitness in the human airway
Zhou, J., Peacock, T. P., Brown, J. C., Goldhill, D. H., Elrefaey, A. M. E., Penrice-Randal, R., Cowton, V. M., De Lorenzo, G., Furnon, W., Harvey, W. T., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110344 · Cited by 64
Addetia, A., Xie, H. J., Roychoudhury, P., Shrestha, L., Loprieno, M. A., Huang, M.-L. W., Jerome, K. R., & Greninger, A. L. (2020) · Journal of Clinical Virology · doi:10.1016/j.jcv.2020.104523 · Cited by 66
Can, H., Köseoğlu, A. E., Alak, S. E., Güvendi, M., Döşkaya, M., Karakavuk, M., Gürüz, A. Y., & Ün, C. (2020) · Scientific Reports · doi:10.1038/s41598-020-79645-9 · Cited by 66
Mutation Signatures and In Silico Docking of Novel SARS-CoV-2 Variants of Concern
Shahhosseini, N., Babuadze, G. G., Wong, G., & Kobinger, G. (2021) · Microorganisms · doi:10.3390/microorganisms9050926 · Cited by 66
Ng, O. T., Koh, V. J. W., Chiew, C. J., Marimuthu, K., Thevasagayam, N. M., Mak, T. M., Chua, J. K., Ong, S. S. H., Lim, Y. K., Ferdous, Z., et al. (2021) · The Lancet Regional Health - Western Pacific · doi:10.1016/j.lanwpc.2021.100299 · Cited by 63
Genomic Perspectives on the Emerging SARS-CoV-2 Omicron Variant
Ma, W., Yang, J., Fu, H., Su, C., Yu, C., Wang, Q., de Vasconcelos, A. T. R., Bazykin, G. A., Bào, Y., & Li, M. (2022) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2022.01.001 · Cited by 59
Genomic assessment of invasion dynamics of SARS-CoV-2 Omicron BA.1
Tsui, J. L.-H., McCrone, J. T., Lambert, B., Bajaj, S., Inward, R. P. D., Bosetti, P., Pena, R. E., Tegally, H., Hill, V., Zarebski, A. E., et al. (2023) · Science · doi:10.1126/science.adg6605 · Cited by 60
Self-citationSkowronski, D. M., Zhan, Y., Kaweski, S. E., Sabaiduc, S., Khalid, A., Olsha, R., Carazo, S., Dickinson, J. A., Mather, R. G., Charest, H., et al. (2024) · Eurosurveillance · doi:10.2807/1560-7917.es.2024.29.7.2400076 · Cited by 65
One year into the pandemic: Short-term evolution of SARS-CoV-2 and emergence of new lineages
Gónzález‐Candelas, F., Shaw, M., Phan, T. G., Kulkarni‐Kale, U., Paraskevis, D. N., Luciani, F., Kimura, H., & Sironi, M. (2021) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2021.104869 · Cited by 65
Immunophenotyping assessment in a COVID-19 cohort (IMPACC): A prospective longitudinal study
IMPACC Manuscript Writing Team, Rouphael, N., Maecker, H. T., Montgomery, R. R., Diray‐Arce, J., Kleinstein, S. H., Altman, M. C., Bosinger, S. E., Eckalbar, W. L., Guan, L., et al. (2021) · Science Immunology · doi:10.1126/sciimmunol.abf3733 · Cited by 58
do Nascimento, V. A., Corado, A. D. L. G., Nascimento, F., Costa, Á., Duarte, D., Luz, S. L. B., Gonçalves, L. M. F., de Jesus, M. S., da Costa, C. F., Delatorre, E. O., et al. (2020) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/0074-02760200310 · Cited by 64
Carreño, J. M., Alshammary, H., Singh, G., Raskin, A. J., Amanat, F., Amoako, A. A., Gonzalez-Reiche, A. S., van de Guchte, A., PARIS study group, Awawda, M. H., et al. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103626 · Cited by 61
SARS-CoV-2 Reverse Zoonoses to Pumas and Lions, South Africa
Koeppel, K. N., Mendes, A., Strydom, A., Rotherham, L. S., Mulumba, M., & Venter, M. (2022) · Viruses · doi:10.3390/v14010120 · Cited by 70
Targeting SARS‐CoV‐2 viral proteases as a therapeutic strategy to treat COVID‐19
Anirudhan, V., Lee, H., Cheng, H., Cooper, L. M., & Rong, L. (2021) · Journal of Medical Virology · doi:10.1002/jmv.26814 · Cited by 63
Hirotsu, Y., & Omata, M. (2021) · Journal of Infection · doi:10.1016/j.jinf.2021.03.013 · Cited by 64
Liu, X.-Q., Luongo, C., Matsuoka, Y., Park, H.-S., Santos, C., Yang, L.-J., Moore, I. N., Afroz, S., Johnson, R. F., Lafont, B., et al. (2021) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.2109744118 · Cited by 60
Humoral immune response after different SARS-CoV-2 vaccination regimens
Rose, R., Neumann, F., Grobe, O., Lorentz, T., Fickenscher, H., & Krumbholz, A. (2022) · BMC Medicine · doi:10.1186/s12916-021-02231-x · Cited by 62
Unlocking capacities of genomics for the COVID-19 response and future pandemics
Knyazev, S., Chhugani, K., Sarwal, V., Ayyala, R., Singh, H., Karthikeyan, S., Deshpande, D., Baykal, P. I., Comarova, Z., Lu, A., et al. (2022) · Nature Methods · doi:10.1038/s41592-022-01444-z · Cited by 61
Spatial and temporal fluctuations in COVID-19 fatality rates in Brazilian hospitals
Brizzi, A., Whittaker, C., Servo, L. M. S., Hawryluk, I., Junior, C. A. P., de Souza, W. M., Aguiar, R. S., de Araújo, L. J. T., Bastos, L. S., Blenkinsop, A., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-01807-1 · Cited by 74
Contributions of adaptation and purifying selection to SARS-CoV-2 evolution
Neher, R. A. (2022) · Virus Evolution · doi:10.1093/ve/veac113 · Cited by 58
Addetia, A., Lin, M. J., Peddu, V., Roychoudhury, P., Jerome, K. R., & Greninger, A. L. (2020) · Journal of Clinical Microbiology · doi:10.1128/jcm.02226-20 · Cited by 59
SARS-CoV-2 Variants and Their Relevant Mutational Profiles: Update Summer 2021
Alkhatib, M., Svicher, V., Salpini, R., Ambrosio, F. A., Bellocchi, M. C., Carioti, L., Piermatteo, L., Scutari, R., Costa, G., Artese, A., et al. (2021) · Microbiology Spectrum · doi:10.1128/spectrum.01096-21 · Cited by 62
Colson, P., Fournier, P., Chaudet, H., Delerce, J., Giraud‐Gatineau, A., Houhamdi, L., Andrieu, C., Bréchard, L., Bedotto, M., Prudent, E., et al. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.786233 · Cited by 64
Stanley, S., Hamel, D. J., Wolf, I. D., Riedel, S. F., Dutta, S., Contreras, E., Callahan, C. J., Cheng, A., Arnaout, R., Kirby, J. E., et al. (2022) · Journal of Clinical Microbiology · doi:10.1128/jcm.00140-22 · Cited by 61
First case of monkeypox virus, SARS-CoV-2 and HIV co-infection
Nolasco, S., Vitale, F. M., Geremia, A., Tramuto, F., Maida, C. M., Sciuto, A., Coco, C., Manuele, R., Frasca, E., Frasca, M., et al. (2022) · Journal of Infection · doi:10.1016/j.jinf.2022.08.014 · Cited by 61
A nidovirus perspective on SARS-CoV-2
Gulyaeva, A. A., & Gorbalenya, A. E. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.11.015 · Cited by 59
Kissler, S. M., Fauver, J. R., Mack, C. D., Tai, C. G.-L., Breban, M. I., Watkins, A. E., Samant, R. M., Anderson, D. J., Ho, D. D., Grubaugh, N. D., et al. (2021) · Digital Access to Scholarship at Harvard (DASH) (Harvard University) · Cited by 60
Detecting SARS-CoV-2 variants with SNP genotyping
Harper, H., Burridge, A. J., Winfield, M., Finn, A. H. R., Davidson, A. D., Matthews, D. A., Hutchings, S., Vipond, B. B., Jain, N., Edwards, K. J., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0243185 · Cited by 60
A Narrative Review of COVID-19 Vaccines
Eroglu, B., Nuwarda, R. F., Ramzan, I. M., & Kayser, V. (2021) · Vaccines · doi:10.3390/vaccines10010062 · Cited by 59
Transmission of SARS-CoV-2 from humans to animals and potential host adaptationPreprint
Tan, C. C. S., Lam, S. D., Richard, D., Owen, C. J., Berchtold, D., Orengo, C. A., Nair, M. S., Kuchipudi, S. V., Kapur, V., van Dorp, L., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.11.16.384743 · Cited by 62
SARS-CoV-2 escape from cytotoxic T cells during long-term COVID-19
Stanevich, O. V., Alekseeva, E. I., Sergeeva, M. V., Fadeev, A. V., Komissarova, K., Ivanova, A. A., Simakova, T., Vasilyev, K., Shurygina, A.-P. S., Stukova, M., et al. (2023) · Nature Communications · doi:10.1038/s41467-022-34033-x · Cited by 60
Tiwari, A., Adhikari, S., Zhang, S., Solomon, T. B., Lipponen, A., Islam, M. A., Thakali, O., Sangkham, S., Shaheen, M. N. F., Jiang, G., et al. (2023) · Water · doi:10.3390/w15061018 · Cited by 61
SARS-CoV-2 variants reveal features critical for replication in primary human cells
Pohl, M. O., Busnadiego, I., Kufner, V., Glas, I., Karakus, U., Schmutz, S., Zaheri, M., Abela, I. A., Trkola, A., Huber, M., et al. (2021) · PLoS Biology · doi:10.1371/journal.pbio.3001006 · Cited by 55
Colson, P., Delerce, J., Burel, E., Dahan, J., Jouffret, A., Fenollar, F., Yahi, N., Fantini, J., Scola, B. L., & Raoult, D. (2022) · Archives of Virology · doi:10.1007/s00705-022-05385-y · Cited by 21
Nikolaidis, M., Papakyriakou, A., Chlichlia, K., Markoulatos, P., Oliver, S. G., & Amoutzias, G. D. (2022) · Viruses · doi:10.3390/v14040707 · Cited by 57
Co-existence and co-infection of influenza A viruses and coronaviruses: Public health challenges
Yang, J., Gong, Y., Zhang, C., Sun, J., Wong, G., Shi, W., Liu, W., Gao, G. F., & Bi, Y. (2022) · The Innovation · doi:10.1016/j.xinn.2022.100306 · Cited by 58
Global SNP analysis of 11,183 SARS‐CoV‐2 strains reveals high genetic diversity
Yuan, F., Wang, L., Fāng, Y., & Wang, L. (2020) · Transboundary and Emerging Diseases · doi:10.1111/tbed.13931 · Cited by 55
Spike2Vec: An Efficient and Scalable Embedding Approach for COVID-19 Spike Sequences
Ali, S., & Patterson, M. (2021) · IEEE International Conference on Big Data (BigData) · doi:10.1109/bigdata52589.2021.9671848 · Cited by 59
López, M. G., Chiner‐Oms, Á., de Viedma, D. G., Ruiz-Rodríguez, P., Bracho, M. A., Cancino‐Muñoz, I., D’Auria, G., Marco, G. D., García‐González, N., Goig, G. A., et al. (2021) · Nature Genetics · doi:10.1038/s41588-021-00936-6 · Cited by 56
Ringlander, J., Fingal, J., Kann, H., Prakash, K., Rydell, G. E., Andersson, M., Martner, A., Lindh, M., Horal, P., Hellstrand, K., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2112663119 · Cited by 57
Emerging SARS-CoV-2 variants: Why, how, and what's next?
Chen, Y. Z., Liu, Q., Zhou, L., Zhou, Y., Yan, H., & Lan, K. (2022) · Cell Insight · doi:10.1016/j.cellin.2022.100029 · Cited by 58
Recent insights into SARS‐CoV‐2 omicron variant
da Silva, S. J. R., Kohl, A., Pena, L., & Pardee, K. (2022) · Reviews in Medical Virology · doi:10.1002/rmv.2373 · Cited by 56
Challenges and Opportunities for Global Genomic Surveillance Strategies in the COVID-19 Era
Ling-Hu, T., Rios-Guzman, E., Lorenzo-Redondo, R., Ozer, E. A., & Hultquist, J. F. (2022) · Viruses · doi:10.3390/v14112532 · Cited by 60
The emergence of SARS-CoV-2 in Europe and the USPreprint
Worobey, M., Pekar, J. E., Larsen, B. B., Nelson, M. I., Hill, V., Joy, J. B., Rambaut, A., Suchard, M. A., Wertheim, J. O., & Lemey, P. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.21.109322 · Cited by 60
Self-citationA persistently replicating SARS-CoV-2 variant derived from an asymptomatic individual
Caccuri, F., Zani, A., Messali, S., Giovanetti, M., Bugatti, A., Campisi, G., Filippini, F., Scaltriti, E., Ciccozzi, M., Fiorentini, S., et al. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02535-1 · Cited by 55
Borges, V., Isidro, J., Macedo, F., Neves, J., Silva, L. R., Paiva, M., Barata, J., Catarino, J., Ciobanu, L. G., Duarte, S., et al. (2021) · Viruses · doi:10.3390/v13040604 · Cited by 56
Detection and characterization of the SARS-CoV-2 lineage B.1.526 in New YorkPreprint
West, A. P., Wertheim, J. O., Wang, J. C., Vasylyeva, T. I., Havens, J. L., Chowdhury, M. A., Gonzalez, E., Fang, C. E., Lonardo, S. S. D., Hughes, S., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.02.14.431043 · Cited by 74
Pathogen-sugar interactions revealed by universal saturation transfer analysis
Buchanan, C. J., Gaunt, B., Harrison, P. J., Yang, Y., Liu, J., Khan, A., Giltrap, A. M., Bas, A. L., Ward, P. N., Gupta, K., et al. (2022) · Science · doi:10.1126/science.abm3125 · Cited by 55
Jacobson, K. B., Pinsky, B. A., Montez Rath, M. E., Wang, H., Miller, J. A., Skhiri, M., Shepard, J., Mathew, R., Lee, G., Bohman, B., et al. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciab554 · Cited by 62
Genomic Epidemiology of the First Wave of SARS-CoV-2 in Italy
Giallonardo, F. D., Duchêne, S., Puglia, I., Curini, V., Profeta, F., Cammà, C., Marcacci, M., Calistri, P., Holmes, E. C., & Lorusso, A. (2020) · Viruses · doi:10.3390/v12121438 · Cited by 56
Self-citationInsights into SARS-CoV-2 Persistence and Its Relevance
Desimmie, B. A., Raru, Y., Awadh, H., He, P., Teka, S., & Willenburg, K. S. (2021) · Viruses · doi:10.3390/v13061025 · Cited by 58
Moubarak, M., Kasozi, K. I., Hetta, . F., Shaheen, H. M., Rauf, A., Al-Kuraishy, H. M., Qusti, S. Y., Alshammari, E. M., Ayikobua, E. T., Ssempijja, F., et al. (2021) · Life · doi:10.3390/life11080734 · Cited by 57
Structural and functional insights into the spike protein mutations of emerging SARS-CoV-2 variants
Gupta, D., Sharma, P., Singh, M., Kumar, M., Ethayathulla, A. S., & Kaur, P. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-04008-0 · Cited by 56
SARS-CoV-2 transmission dynamics in Belarus in 2020 revealed by genomic and incidence data analysis
Nemira, A., Adeniyi, A. E., Леонидовна, Г. Е., Bulda, K. Y., Valentovich, L. N., Kras’ko, A. G., Glebova, O., Kirpich, A., & Skums, P. (2021) · Communications Medicine · doi:10.1038/s43856-021-00031-1 · Cited by 55
Assessing Uncertainty in the Rooting of the SARS-CoV-2 Phylogeny
Pipes, L., Wang, H., Huelsenbeck, J. P., & Nielsen, R. (2020) · Molecular Biology and Evolution · doi:10.1093/molbev/msaa316 · Cited by 55
Bioinformatics resources for SARS-CoV-2 discovery and surveillance
Hu, T., Li, J., Zhou, H., Li, C., Holmes, E. C., & Shi, W. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa386 · Cited by 57
Self-citationAgrawal, S., Orschler, L., Tavazzi, S., Greither, R., Gawlik, B. M., & Lackner, S. (2022) · Microbiology Resource Announcements · doi:10.1128/mra.01229-21 · Cited by 54
COVID-19 at a Glance: An Up-to-Date Overview on Variants, Drug Design and Therapies
Iacopetta, D., Ceramella, J., Catalano, A. A., Saturnino, C., PELLEGRINO, M. A., Mariconda, A., Longo, P., Sinicropi, M. S., & Aquaro, S. (2022) · Viruses · doi:10.3390/v14030573 · Cited by 54
Diray‐Arce, J., Fourati, S., Jayavelu, N. D., Patel, R. K., Maguire, C. P., Chang, A. C., Dandekar, R., Qi, J., Lee, B. H., van Zalm, P., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101079 · Cited by 49
Genomic epidemiology of SARS-CoV-2 in a UK university identifies dynamics of transmission
Aggarwal, D., Warne, B., Jahun, A. S., Hamilton, W. L., Fieldman, T., du Plessis, L., Hill, V., Blane, B., Watkins, E., Wright, E., et al. (2022) · Nature Communications · doi:10.1038/s41467-021-27942-w · Cited by 48
Self-citationLamba, S., Ganesan, S., Daroch, N., Paul, K., Joshi, S. G., Sreenivas, D., Nataraj, A., Srikantaiah, V., Mishra, R. K., Ramakrishnan, U., et al. (2023) · The Lancet Regional Health - Southeast Asia · doi:10.1016/j.lansea.2023.100151 · Cited by 53
Molecular Tracing of SARS-CoV-2 in Italy in the First Three Months of the Epidemic
Lai, A., Bergna, A., Caucci, S., Clementi, N., Vicenti, I., Dragoni, F., Cattelan, A. M., Menzo, S., Pan, A., Callegaro, A., et al. (2020) · Viruses · doi:10.3390/v12080798 · Cited by 52
The Antibody Response to SARS-CoV-2 Infection
Hueston, L., Kok, J., Guibone, A., McDonald, D., Hone, G., Goodwin, J., Carter, I. W. J., Basile, K., Sandaradura, I., Maddocks, S., et al. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa387 · Cited by 50
A review on favipiravir: the properties, function, and usefulness to treat COVID-19
Hashemian, S. M. R., Farhadi, T., & Velayati, A. A. (2020) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2021.1866545 · Cited by 53
Dominance of Alpha and Iota variants in SARS-CoV-2 vaccine breakthrough infections in New York City
Duerr, R., Dimartino, D., Marier, C., Zappile, P., Wang, G., Lighter, J., Elbel, B. D., Troxel, A. B., & Heguy, A. (2021) · Journal of Clinical Investigation · doi:10.1172/jci152702 · Cited by 53
SARS-CoV-2 in residential rooms of two self-isolating persons with COVID-19
Shankar, S. N., Witanachchi, C. T., Morea, A. F., Lednicky, J. A., Loeb, J. C., Alam, M. M., Fan, Z. H., Eiguren-Fernandez, A., & Wu, C. (2021) · Journal of Aerosol Science · doi:10.1016/j.jaerosci.2021.105870 · Cited by 52
Naveca, F. G., do Nascimento, V. A., de Souza, V. C., Corado, A. D. L. G., Nascimento, F., Silva, G., Mejía, M., Brandão, M. J., Costa, Á., Duarte, D., et al. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.02366-21 · Cited by 54
Emergence and widespread circulation of a recombinant SARS-CoV-2 lineage in North America
Gutiérrez, B., Castelán-Sánchez, H. G., Cândido, D. D. S., Jackson, B., Fleishon, S., Houzet, R., Ruis, C., Delaye, L., Faria, N. R., Rambaut, A., et al. (2022) · Cell Host & Microbe · doi:10.1016/j.chom.2022.06.010 · Cited by 55
Self-citationBolze, A., Cirulli, E. T., Luo, S., White, S., Wyman, D., Dei Rossi, A., Machado, H., Cassens, T., Jacobs, S., Schiabor Barrett, K. M., et al. (2021) · doi:10.1101/2021.06.20.21259195 · Cited by 116
Tablizo, F. A., Kim, K. M., Lapid, C. M., Castro, M. J. R., Yangzon, M. S. L., Maralit, B. A., Ayes, M. E. C., Cutiongco-de la Paz, E. M., De Guzman, A. R., Yap, J. M. C., et al. (2021) · doi:10.1101/2021.03.03.21252812 · Cited by 46
Xavier, J., Giovanetti, M., Adelino, T., Fonseca, V., da Costa, A. V. B., Ribeiro, A. A., Felicio, K. N., Guerra-Duarte, C., Silva, M. V. F., Salgado, Á., et al. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1803146 · Cited by 51
Self-citationRueca, M., Bartolini, B., Gruber, C. E. M., Piralla, A., Baldanti, F., Giombini, E., Messina, F., Marchioni, L., Ippolito, G., Di, A., et al. (2020) · Microorganisms · doi:10.3390/microorganisms8091302 · Cited by 49
Local Transmission of SARS-CoV-2 Lineage B.1.1.7, Brazil, December 2020
Claro, I. M., Sales, F. C. D. S., Ramundo, M. S., Cândido, D. D. S., da Silva, C. A. M., de Jesus, J. G., Manuli, E. R., de Oliveira, C. M., Scarpelli, L. C., Campana, G., et al. (2021) · Emerging infectious diseases · doi:10.3201/eid2703.210038 · Cited by 51
Self-citationAn outbreak of SARS-CoV-2 with high mortality in mink (Neovison vison) on multiple Utah farms
Eckstrand, C., Baldwin, T. J., Torchetti, M. K., Killian, M. L., Rood, K. A., Clayton, M. J., Lott, J. K., Wolking, R. M., Bradway, D. S., & Baszler, T. V. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009952 · Cited by 56
Zhao, Z., Sokhansanj, B. A., Malhotra, C., Zheng, K., & ROSEN, G. L. (2020) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1008269 · Cited by 51
A Genome Epidemiological Study of SARS-CoV-2 Introduction into Japan
Sekizuka, T., Itokawa, K., Hashino, M., Kawano-Sugaya, T., Tanaka, R., Yatsu, K., Ohnishi, A., Goto, K., Tsukagoshi, H., Ehara, H., et al. (2020) · mSphere · doi:10.1128/msphere.00786-20 · Cited by 49
Benning, L., Morath, C. P., Bartenschlager, M., Kim, H., Reineke, M., Beimler, J., Buylaert, M., Nußhag, C., Kälble, F., Reichel, P., et al. (2022) · American Journal of Transplantation · doi:10.1111/ajt.17054 · Cited by 51
TBEV Subtyping in Terms of Genetic Distance
Deviatkin, A. A., Karganova, G. G., Vakulenko, Y. A., & Lukashev, A. N. (2020) · Viruses · doi:10.3390/v12111240 · Cited by 49
Paiva, M. H. S., Guedes, D. R. D., Docena, C., Bezerra, M. F., Dezordi, F. Z., Machado, L. C., Krokovsky, L., Helvécio, E., da Silva, A. F., Vasconcelos, L. R. S., et al. (2020) · Viruses · doi:10.3390/v12121414 · Cited by 49
SARS-CoV-2 Lineages and Sub-Lineages Circulating Worldwide: A Dynamic Overview
Cella, E., Benedetti, F., Fabris, S., Borsetti, A., Pezzuto, A., Ciotti, M., Pascarella, S., Ceccarelli, G., Zella, D., Ciccozzi, M., et al. (2021) · Chemotherapy · doi:10.1159/000515340 · Cited by 48
Novavax NVX-COV2373 triggers neutralization of Omicron sub-lineages
Bhiman, J. N., Richardson, S. I., Lambson, B. E., Kgagudi, P., Mzindle, N. B., Kaldine, H., Crowther, C. E., Gray, G., Bekker, L., Koen, A. L., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-27698-x · Cited by 49
Li, P., Liu, Y., Faraone, J. N., Hsu, C. C., Chamblee, M., Zheng, Y.-M., Carlin, C., Bednash, J. S., Horowitz, J. C., Mallampalli, R. K., et al. (2024) · mBio · doi:10.1128/mbio.00751-24 · Cited by 49
Genomic epidemiology of SARS-CoV-2 under an elimination strategy in Hong Kong
Gu, H., Xie, R., Adam, D. C., Tsui, J. L.-H., Chu, D. K. W., Chang, L. D. J., Cheuk, S. S. Y., Gurung, S., Krishnan, P., Ng, D. Y. M., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28420-7 · Cited by 46
Lubinski, B., Frazier, L. E., Phan, M. V. T., Bugumbe, D., Cunningham, J. L., Tang, T., Daniel, S., Cotten, M. L., Jaimes, J. A., & Whittaker, G. R. (2021) · SSRN Electronic Journal · doi:10.1101/2021.06.30.450632 · Cited by 49
A mixture model for determining SARS-Cov-2 variant composition in pooled samplesPreprint
Valieris, R., Drummond, R. D., Defelicibus, A., Dias-Neto, E., Rosales, R., & da Silva, I. T. (2021) · arXiv (Cornell University) · doi:10.1093/bioinformatics/btac047 · Cited by 49
COVID-19, the first pandemic in the post-genomic era
van Dorp, L., Houldcroft, C. J., Richard, D., & Balloux, F. (2021) · Current Opinion in Virology · doi:10.1016/j.coviro.2021.07.002 · Cited by 49
Chen, L., Lu, L., Choi, C. Y.-K., Cai, J., Tsoi, H., Chu, A. W., Ip, J. D., Chan, W.-M., Zhang, R., Zhang, X., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab656 · Cited by 48
Heide, J., Schulte, S., Kohsar, M., Brehm, T. T., Herrmann, M., Karsten, H., Marget, M., Peine, S., Johansson, A. M., Sette, A., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009842 · Cited by 46
The twin-beginnings of COVID-19 in Asia and Europe—one prevails quickly
Ruan, Y., Wen, H., Hou, M., He, Z., Lu, X., Xue, Y., He, X., Zhang, Y., & Wu, C. (2021) · National Science Review · doi:10.1093/nsr/nwab223 · Cited by 46
PARNAS: Objectively Selecting the Most Representative Taxa on a Phylogeny
Markin, A., Wagle, S., Grover, S., Baker, A. L. V., Eulenstein, O., & Anderson, T. K. (2023) · Systematic Biology · doi:10.1093/sysbio/syad028 · Cited by 48
Fitness, growth and transmissibility of SARS-CoV-2 genetic variants
Volz, E. (2023) · Nature Reviews Genetics · doi:10.1038/s41576-023-00610-z · Cited by 51
SARS‐CoV‐2 virulence evolution: Avirulence theory, immunity and trade‐offs
Alizon, S., & Sofonea, M. T. (2021) · Journal of Evolutionary Biology · doi:10.1111/jeb.13896 · Cited by 53
Genetic diversity of SARS-CoV-2 infections in Ghana from 2020-2021
Morang’a, C. M., Ngoi, J. M., Gyamfi, J., Amuzu, D. S. Y., Nuertey, B. D., Soglo, P. M., Appiah, V., Asante, I. A., Owusu-Oduro, P., Armoo, S., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30219-5 · Cited by 48
Metadata
- Authors
- Rambaut, A., Holmes, E. C., O’Toole, Á., Hill, V., McCrone, J. T., Ruis, C., du Plessis, L., & Pybus, O. G.
- Affiliations
- University of Edinburgh (GB)
- The University of Sydney (AU)
- University of Cambridge (GB)
- University of Oxford (GB)
- Corresponding author
- Rambaut, Andrew
- Holmes, Edward C.
- Pybus, Oliver G.
- ORCID
- Venue
- Nature Microbiology
- Published
- 2020-07-15
- Volume
- 5
- Issue
- 11
- Pages
- 1403-1407
- ISSN
- 2058-5276 (ISSN-L)
- PMC
- PMC7610519
- OpenAlex
- W3043124965
- Cited by
- 2,543
- References
- 18
- Citations by year
- 2026: 86 · 2025: 141 · 2024: 235 · 2023: 365 · 2022: 700 · 2021: 851 · 2020: 163
- FWCI
- 68.76
- Type
- journal article
- Language
- en
- Update notices
- addendum (2021-01-29)
- Open access
- bronze
- doi.org
- Licence
- Locations
- Nature Microbiology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
- The Sydney eScholarship Repository (The University of Sydney) (submittedVersion)
- Funders
- Wellcome Trust (206298/Z/17/Z-ARTIC, FP7/2007–2013, Z/17/Z, 206298/Z/17/Z, 206298, 725422-ReservoirDOCS)
- European Commission (725422, 725422-RESERVOIRDOCS, 2007–2013, FP7 2007-2013, HORIZON2020, FP7/2007, COVID-19)
- Australian Research Council (FL170100022)
- FP7 Ideas: European Research Council (614725)
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Phylogenetic Studies
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 detection and testing
- Keywords
- SARS-CoV-2, COVID-19 pandemic, virus nomenclature, phylogenetic lineages, genomic epidemiology
- MeSH terms
- Betacoronavirus, COVID-19, SARS-CoV-2, Genotype, Humans, Phylogeny, Pneumonia, Viral, Genome, Viral, Molecular Epidemiology, Coronavirus Infections, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review